Skip to main content

Table 4 Microvascular density levels at various levels of clinico-pathological variables. The adjacent table reports median MVD levels at different levels of clinico-pathological variables. None of the comparisons are statistically significant

From: Angiogenesis in male breast cancer

 

Age group

Tumor size

Node status

 

<65 years

<65 years

T1

T2

T3

Negative

Positive

VWF

              

   AMC

15.6

(5.7)

15.0

(5.8)

15.8

(5.5)

13.5

(5.3)

17.5

(27.9)

14.2

(5.2)

15.6

(5.2)

   CMC

53.7

(24.7)

47.2

(50.2)

44.8

(30.5)

50.3

(43.7)

67.5

(40.3)

48.5

(39.8)

50.0

(35.6)

   HMC

84.0

(50.3)

70.0

(48.5)

86.5

(48.6)

69.0

(58.5)

70.0

(41.8)

84.0

(53.5)

69.3

(44.0)

CD31

              

   AMC

5.9

(20.9)

14.5

(28.8)

6.8

(28.6)

11.4

(30.5)

15.4

(61.7)

7.2

(17.9)

10.4

(32.6)

   CMC

18.8

(41.4)

26.2

(28.6)

15.7

(38.0)

29.3

(28.9)

20.7

(81.0)

17.9

(33.7)

32.5

(36.5)

   HMC

36.5

(44.8)

38.0

(27.0)

28.0

(40.0)

43.6

(22.3)

30.0

(107.4)

35.9

(40.0)

43.0

(42.6)

CD34

              

   AMC

19.7

(9.6)

19.8

(10.5)

21.0

(9.0)

17.3

(11.5)

20.0

(81.8)

18.8

(8.3)

19.9

(11.4)

   CMC

52.0

(21.8)

41.3

(35.0)

43.3

(29.4)

52.0

(34.2)

48.5

(46.5)

47.2

(35.0)

50.7

(29.0)

   HMC

89.0

(50.5)

70.0

(77.0)

79.0

(54.3)

86.0

(83.1)

88.0

(79.2)

90.0

(63.3)

70.0

(60.9)

CD105

              

   AMC

2.7

(4.4)

4.4

(4.3)

2.7

(3.8)

4.4

(5.4)

5.4

(10.0)

3.0

(4.7)

4.0

(3.6)

   CMC

8.8

(14.3)

10.7

(13.2)

7.0

(13.8)

10.9

(14.9)

14.3

(31.7)

9.2

(14.5)

10.2

(10.6)

   HMC

29.0

(24.5)

32.0

(34.5)

28.5

(30.3)

30.5

(49.3)

39.0

(156.0)

26.5

(33.0)

31.0

(20.0)

VEGF

              

   AMC

7.5

(20.0)

17.9

(25.1)

11.9

(25.5)

15.4

(26.8)

5.8

(64.9)

13.4

(21.8)

13.2

(29.2)

   CMC

42.5

(47.0)

39.4

(33.6)

47.5

(72.9)

40.8

(39.5)

36.3

(45.6)

41.1

(45.1)

42.3

(58.8)

   HMC

58.8

(103.1)

80.0

(87.6)

70.3

(113.6)

66.0

(79.1)

80.0

(55.9)

69.8

(86.2)

79.0

(92.8)

  1. None of the differences between levels of age or clinico-pathological variables are statistically significant